Journal
ADVANCED MATERIALS
Volume 25, Issue 39, Pages 5632-+Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma201301804
Keywords
-
Categories
Funding
- US Army Medical Research Acquisition Act (USAMRAA) [W81XWH-10-1-0434]
- IMI Program of the National Science Foundation [DMR 0843934]
- George and Barbara Bush Endowment for Innovative Cancer Research
- Cancer Center Support Grant from the National Cancer Institute [CA16672]
- Direct For Mathematical & Physical Scien [0843934] Funding Source: National Science Foundation
- Division Of Materials Research [0843934] Funding Source: National Science Foundation
Ask authors/readers for more resources
Fluorinated graphene oxide (FGO) is reported for the first time as a magnetically responsive drug carrier that can serve both as a magnetic resonance imaging (MRI) and photoacoustic contrast agent, under preclinical settings, and as a type of photothermal therapy. Its hydrophilic nature facilitates biocompatibility. FGO as a broad wavelength absorber, with high charge transfer and strong non-linear scattering is optimal for NIR laser-induced hyperthermia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
